Navigation Links
Amsterdam Molecular Therapeutics Reports Full Year Results 2007
Date:2/19/2008

payables 2,168 963

Payables to related parties 730 266

Social security and other taxes 227 153

Other current liabilities 2,701 1,433

5,826 2,815

Total liabilities 6,832 19,900

Total equity and liabilities 58,239 18,218

Consolidated cash flow statement

(In EUR x 1,000)

Year ended

31 December 2007 31 December 2006

(Unaudited) (Unaudited)

Cash flow from operating activities

Result before corporate income tax (14,935) (8,760)

Adjustments for:

- Depreciation 334 319

- Share-based payment expenses 1,143 159

- Gain on derecognition financial - 25

lease

- Re-purchase of EMT sales rights - 1,736

- Gain on deconsolidation AVP - (1,113)

- Changes in working capital 1,003 420

- Interest income/(expense) 275 789

Cash used in operations (12,180) (6,425)

Interest paid - (86)

Net cash generated from operating (12,180) (6,511)

activities

Cash flow from investing activities

Purchases of property, plant and (1,345) (387)

equipment
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
2. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
3. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
4. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
5. Acrongenomics on Track to Acquire Molecular Vision
6. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
7. Acrongenomics Acquires Equity Stake in Molecular Vision
8. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
9. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
10. Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
11. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The wor...re in turmoil and uncertainty is part of many,busi...a industry has been,relatively immune to the econo...ion. , During the midst of the difficult ...& Johnson inaugurated an R&D center in Sha...
(Date:12/2/2009)...OBOKEN, N.J., Dec. 2 According to ... percent of Americans diagnosed with diabetes alre...etic retinopathy, damage to the retina caused by l...in people with diabetes and is one of the most fea...cent of all patients who,ve had diabetes for 10 ye...
(Date:12/1/2009)...LINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall/ ...y announced revenue guidance for the fourth quarte...lion, as compared with $69 million for the fourth ...esults was the first of two installment payments o...urth quarter 2008 results was a one-time $1.8 mill...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.... available in its catalogue: ,, Industrial Enz...eportlinker.com/p0164431/Industrial-Enzymes---A-Gl...market is an oligopoly with few strong players and... activities. Keen competition and commoditization ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...ical communications bear more than a passing resem...ot wish literally to capture all the colors of the... which light from across the spectrum moves throug...en those circuits contain dimensions measured in n..., a Ph.D. candidate in electrical engineering at L...
... Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotechn...nds for the treatment of cardiovascular disease, w...nvestments reconstitutes its family of,U.S. indexe...eliminary list,of additions posted on http://www....ed for inclusion in this objective,market-driven i...
...d security guards came to the DHS Science and Tech... heading their list was an emergency escape hood w...le hood weighing under a pound, folding to the dim.... , Furthermore, the hood must be maintenance-f...ve toxic industrial chemicals, and fit two-to-a-br...
Other Biology Technology:Using a grating with a grade, engineers trap a rainbow 2Using a grating with a grade, engineers trap a rainbow 3VIA Pharmaceuticals Set to Join Russell Microcap Index 2VIA Pharmaceuticals Set to Join Russell Microcap Index 3VIA Pharmaceuticals Set to Join Russell Microcap Index 4Boys in the Hood 2
(Date:12/3/2009)...nd adapt to changes in our daily environment, as w... in the minute junctions where nerve cells communi...cine Center researchers. The study is published on...cientists, led by Wen-Biao Gan, PhD, associate pro...l of Medicine, discovered that a delicate balancin...
(Date:12/3/2009)...ieve that staph infections are caused by many bact... The signaling process is called quorum sensing be...rocess. , But the Jeff Brinker research group ha...fection, when bacteria switch from a harmless to a...his individual process can be stopped by the appli...
(Date:12/3/2009)...levels for the past three years in the troposphere...l area near Valladolid. The results, which are the...w that the levels rose "significantly" between 200...meteorologists have been trying to find out about ...olved in the troposphere over various urban and ru...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 1Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 2Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 3The Crohns 26 Colitis Foundation and Procter 26 Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 49883 1The Crohns 26 Colitis Foundation and Procter 26 Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 49883 2The Crohns 26 Colitis Foundation and Procter 26 Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 49883 3The Crohns 26 Colitis Foundation and Procter 26 Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 49883 4The Crohns 26 Colitis Foundation and Procter 26 Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners 49883 5Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infect 49878 1Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infect 49878 2Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infect 49878 3
...ociety has consisted in the development of class a...by the other". Karl Marx and Frederick Engels, T...social groups can increase group well being, it al...cieties are characterized by struggles for control... in the fields. In colonies of social insects this...
... for the performance horse industry (such as racin...rness stem cells to repair tendon, ligament, carti...from the Monash Institute of Medical Research, is ...uine embryonic stem cell lines, with the aim of cr...preserved for individual horses. , Damage to tend...
... and climate experts from the UK,s National Centre...ile to investigate how massive swathes of clouds t...d weather all round the world, including the UK. ...gest errors currently in our climate models and th...hange. , These immense clouds often exceeding ...
Other Biology News:Caste in the colony 2Stem cell research to benefit horse owners and trainers 2British scientists go cloud-hopping in the Pacific to improve climate predictions 2
Rabbit Anti-DcR2 Polyclonal Antibody, Unconjugated from Abcam
Fau I from New England Biolabs
Mouse Anti-Human Angiogenin Monoclonal Antibody, Unconjugated, Clone 14017.7 from Sigma-Aldrich
Hae III from Takara Mirus Bio
Biology Products: